199 related articles for article (PubMed ID: 34556105)
1. Peripheral quantitative computed tomography in the assessment of bone mineral density in anti-TNF-treated rheumatoid arthritis and ankylosing spondylitis patients.
Juhász B; Gulyás K; Horváth Á; Végh E; Pusztai A; Szentpétery Á; Pethő Z; Bodnár N; Hamar A; Bodoki L; Bhattoa HP; Szekanecz É; Hodosi K; Domján A; Szamosi S; Horváth C; Szántó S; Szűcs G; Raterman HG; Lems WF; FitzGerald O; Szekanecz Z
BMC Musculoskelet Disord; 2021 Sep; 22(1):817. PubMed ID: 34556105
[TBL] [Abstract][Full Text] [Related]
2. Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis.
Gulyás K; Horváth Á; Végh E; Pusztai A; Szentpétery Á; Pethö Z; Váncsa A; Bodnár N; Csomor P; Hamar A; Bodoki L; Bhattoa HP; Juhász B; Nagy Z; Hodosi K; Karosi T; FitzGerald O; Szücs G; Szekanecz Z; Szamosi S; Szántó S
Clin Rheumatol; 2020 Jan; 39(1):167-175. PubMed ID: 31522318
[TBL] [Abstract][Full Text] [Related]
3. Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls.
Juhász B; Gulyás K; Horváth Á; Pethő Z; Bhattoa HP; Váncsa A; Szekanecz É; Horváth C; Kocsis J; Horváth Z; Hodosi K; Szántó S; Szűcs G; Szekanecz Z
Osteoporos Int; 2017 Apr; 28(4):1271-1277. PubMed ID: 27942777
[TBL] [Abstract][Full Text] [Related]
4. Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis.
Hamar A; Szekanecz Z; Pusztai A; Czókolyová M; Végh E; Pethő Z; Bodnár N; Gulyás K; Horváth Á; Soós B; Bodoki L; Bhattoa HP; Nagy G; Tajti G; Panyi G; Szekanecz É; Domján A; Hodosi K; Szántó S; Szűcs G; Szamosi S
Osteoporos Int; 2021 Aug; 32(8):1621-1629. PubMed ID: 33559714
[TBL] [Abstract][Full Text] [Related]
5. Associations of vascular and bone status in arthritis patients.
Pusztai A; Hamar A; Czókolyová M; Gulyás K; Horváth Á; Végh E; Pethő Z; Szamosi S; Balogh E; Bodnár N; Bodoki L; Szentpétery Á; Bhattoa HP; Kerekes G; Juhász B; Szekanecz É; Hodosi K; Domján A; Szántó S; Raterman HG; Lems WF; Szekanecz Z; Szűcs G
Sci Rep; 2021 Sep; 11(1):19504. PubMed ID: 34593938
[TBL] [Abstract][Full Text] [Related]
6. Skeletal status of men with early and late ankylosing spondylitis.
Lee YS; Schlotzhauer T; Ott SM; van Vollenhoven RF; Hunter J; Shapiro J; Marcus R; McGuire JL
Am J Med; 1997 Sep; 103(3):233-41. PubMed ID: 9316556
[TBL] [Abstract][Full Text] [Related]
7. Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology.
Czókolyová M; Pusztai A; Végh E; Horváth Á; Szentpéteri A; Hamar A; Szamosi S; Hodosi K; Domján A; Szántó S; Kerekes G; Seres I; Harangi M; Paragh G; Szekanecz É; Szekanecz Z; Szűcs G
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680168
[TBL] [Abstract][Full Text] [Related]
8. Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis.
Végh E; Kerekes G; Pusztai A; Hamar A; Szamosi S; Váncsa A; Bodoki L; Pogácsás L; Balázs F; Hodosi K; Domján A; Szántó S; Nagy Z; Szekanecz Z; Szűcs G
Rheumatol Int; 2020 Mar; 40(3):427-436. PubMed ID: 31848735
[TBL] [Abstract][Full Text] [Related]
9. Baseline new bone formation does not predict bone loss in ankylosing spondylitis as assessed by quantitative computed tomography (QCT): 10-year follow-up.
Korkosz M; Gąsowski J; Grzanka P; Gorczowski J; Pluskiewicz W; Jeka S; Grodzicki T
BMC Musculoskelet Disord; 2011 May; 12():121. PubMed ID: 21627836
[TBL] [Abstract][Full Text] [Related]
10. Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors.
Malluche HH; Monier-Faugere MC; Blomquist G; Davenport DL
Osteoporos Int; 2018 Jan; 29(1):125-134. PubMed ID: 28993865
[TBL] [Abstract][Full Text] [Related]
11. Quantitative computed tomography (QCT) of the forearm using general purpose spiral whole-body CT scanners: accuracy, precision and comparison with dual-energy X-ray absorptiometry (DXA).
Engelke K; Libanati C; Liu Y; Wang H; Austin M; Fuerst T; Stampa B; Timm W; Genant HK
Bone; 2009 Jul; 45(1):110-8. PubMed ID: 19345291
[TBL] [Abstract][Full Text] [Related]
12. Denosumab improves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone mineral density.
Genant HK; Engelke K; Hanley DA; Brown JP; Omizo M; Bone HG; Kivitz AJ; Fuerst T; Wang H; Austin M; Libanati C
Bone; 2010 Jul; 47(1):131-9. PubMed ID: 20399288
[TBL] [Abstract][Full Text] [Related]
13. Administration of romosozumab improves vertebral trabecular and cortical bone as assessed with quantitative computed tomography and finite element analysis.
Graeff C; Campbell GM; Peña J; Borggrefe J; Padhi D; Kaufman A; Chang S; Libanati C; Glüer CC
Bone; 2015 Dec; 81():364-369. PubMed ID: 26232375
[TBL] [Abstract][Full Text] [Related]
14. Thoracic Quantitative Computed Tomography (QCT) Can Sensitively Monitor Bone Mineral Metabolism: Comparison of Thoracic QCT vs Lumbar QCT and Dual-energy X-ray Absorptiometry in Detection of Age-relative Change in Bone Mineral Density.
Mao SS; Li D; Syed YS; Gao Y; Luo Y; Flores F; Child J; Cervantes M; Kalantar-Zadeh K; Budoff MJ
Acad Radiol; 2017 Dec; 24(12):1582-1587. PubMed ID: 28844601
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density, bone metabolism-related factors, and microRNA-218 are correlated with disease activities in Chinese ankylosing spondylitis patients.
Liu J; Zhao L; Yang X; Liu C; Kong N; Yu Y; Xuan D; Wan W; Xue Y
J Clin Lab Anal; 2022 Feb; 36(2):e24223. PubMed ID: 34984723
[TBL] [Abstract][Full Text] [Related]
16. Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis.
Bauer DC; Garnero P; Bilezikian JP; Greenspan SL; Ensrud KE; Rosen CJ; Palermo L; Black DM
J Clin Endocrinol Metab; 2006 Apr; 91(4):1370-5. PubMed ID: 16449339
[TBL] [Abstract][Full Text] [Related]
17. Soluble Vascular Biomarkers in Rheumatoid Arthritis and Ankylosing Spondylitis: Effects of 1-year Antitumor Necrosis Factor-α Therapy.
Pusztai A; Hamar A; Horváth Á; Gulyás K; Végh E; Bodnár N; Kerekes G; Czókolyová M; Szamosi S; Bodoki L; Hodosi K; Domján A; Nagy G; Szöllősi I; Lopez LR; Matsuura E; Prohászka Z; Szántó S; Nagy Z; Shoenfeld Y; Szekanecz Z; Szűcs G
J Rheumatol; 2021 Jun; 48(6):821-828. PubMed ID: 33323530
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification.
Grampp S; Genant HK; Mathur A; Lang P; Jergas M; Takada M; Glüer CC; Lu Y; Chavez M
J Bone Miner Res; 1997 May; 12(5):697-711. PubMed ID: 9144335
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients.
Soós B; Fagyas M; Horváth Á; Végh E; Pusztai A; Czókolyová M; Csongrádi A; Hamar A; Pethő Z; Bodnár N; Kerekes G; Hodosi K; Szekanecz É; Szamosi S; Szántó S; Szűcs G; Papp Z; Szekanecz Z
Front Med (Lausanne); 2021; 8():785744. PubMed ID: 35155468
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of tissue inhibitor of metalloproteinase-1 and periarticular bone loss in early rheumatoid arthritis.
Murphy E; Roux-Lombard P; Rooney T; Fitzgerald O; Dayer JM; Bresnihan B
Clin Rheumatol; 2009 Mar; 28(3):285-91. PubMed ID: 19050823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
